Evidence map›Paper›PMID 40842948›Full record

ArticleFrontiers in psychiatry2025

Improved mental health outcomes and normalised spontaneous EEG activity in veterans reporting a history of traumatic brain injuries following participation in a psilocybin retreat.

Grace Blest-Hopley, Giuseppe Pasculli, Simon G D Ruffell, WaiFung Tsang, Olateju Emmanuel, Kathryn M Pate, Hannes Kettner, Leor Roseman, David Erritzoe, Robin Carhart-Harris

Abstract read
In one paragraph

Article in Frontiers in psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Grace Blest-HopleyKing's College London, Institute of Psychiatry, Psychology and Neuroscience, London, United Kingdom.
Giuseppe PasculliDepartment of Computer, Automatic and Management Engineering, Faculty of Information Engineering, Computer Science and Statistics (DIAG), Sapienza University of Rome, Rome, Italy.
Simon G D RuffellDepartment of Psychology, University of Exeter Onaya Science, Iquitos, Peru.
WaiFung TsangKing's College London, Institute of Psychiatry, Psychology and Neuroscience, London, United Kingdom.
Olateju EmmanuelApplied Artificial Intelligence and Robotics Research Laboratory, Department of Electronic and Electrical Engineering, Obafemi Awolowo University, Ife, Nigeria.
Kathryn M PateR&D, Coruna Medical LLC, Longmont, CO, United States.
Hannes KettnerDepartment of Medicine, Centre for Psychedelic Research, Imperial College London, London, United Kingdom.
Leor RosemanDepartment of Psychology, University of Exeter, Exeter, United Kingdom.
David ErritzoeDepartment of Medicine, Centre for Psychedelic Research, Imperial College London, London, United Kingdom.
Robin Carhart-HarrisDepartment of Medicine, Centre for Psychedelic Research, Imperial College London, London, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Psilocybin, a serotonergic psychedelic, has shown therapeutic potential in treating mental health disorders by, amongst the many effects, promoting neuroplasticity and reorganising functional connectivity across cortical and subcortical networks involved in emotion and cognition. Veterans with traumatic brain injuries (TBI) often experience chronic neurological and psychological symptoms such as post-traumatic stress disorder (PTSD) and depression. This study investigates the effects of psilocybin administered in retreat settings on veterans with a history of TBI, focusing on mental health outcomes and changes in brain connectivity as measured by EEG. Methods: A total of 21 participants were recruited through the Heroic Hearts Project, which facilitated access to two six-day psilocybin retreats in Jamaica. Before the retreat, participants underwent three individual and three group coaching sessions to prepare for the experience. During the retreat, two psilocybin ceremonies were held, spaced 48 hours apart. Participants received an initial dose of 1.5g to 3.5g of dried psilocybin mushrooms, with the option to increase the second dose up to 5g. Psilocybin was administered in a tea format, under the supervision of experienced facilitators. Psychological outcomes were assessed using validated questionnaires (PCL-5, PHQ-9, STAI) at baseline (four weeks pre-retreat) and four weeks post-retreat. Electroencephalography (EEG) was used to measure brainwave activity pre- and post-treatment. Paired t-tests were used to analyze changes in psychological scores, while EEG frequency band analysis assessed changes in brain function and connectivity. Results: Improvements were observed across several mental health measures: PTSD (PCL-5 scores decreased by 50%, p=0.010), depression (PHQ-9 scores decreased by 65%, p<0.001), and anxiety (STAI) scores decreased by 28%, p<0.001). EEG data showed decreased delta and theta power in frontal and temporal regions, indicating potential improvements in cognitive control and emotional processing. Enhanced coherence in alpha and beta bands suggested improved neural communication. Discussion: The study suggests that psilocybin retreats might provide improvements in psychological well-being and brain connectivity in veterans with TBI. Reduced delta power and normalised theta activity suggest better emotional regulation, while improved coherence in alpha and beta bands may reflect increased cognitive engagement. Further, these preliminary outcomes provide a potential rationale for the design and implementation of larger-scale, controlled studies to validate and expand upon these initial findings.

Indexed as

EEGmental healthneuroplasticitypsilocybinpsychedelic therapyPTSDtraumatic brain injuryveterans

Identifiers

PMID40842948
PMCPMC12364870

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.